Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525004 · ClinicalTrials.gov registry record · Phase 1
Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01525004 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 38 participants.
The verdict
NCT01525004, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
This is a phase I trial in which the both the safety and immunogenicity of the standard dose flu vaccine will be compared with high dose flu vaccine in children that have undergone solid organ transplantation (SOT).
Interventions
- DRUG Standard dose trivalent inactivated influenza vaccine
- DRUG High-Dose trivalent inactivated influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01525004
The ClinicalTrials.gov registry entry for NCT01525004 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard dose trivalent inactivated influenza vaccine is the first listed.
NCT01525004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01525004 about?
NCT01525004 is a clinical study titled "Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients". This is a phase I trial in which the both the safety and immunogenicity of the standard dose flu vaccine will be compared with high dose flu vaccine in children that have undergone solid organ transplantation (SOT).
What is the current status of trial NCT01525004?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2011-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01525004?
The interventions under investigation include: Standard dose trivalent inactivated influenza vaccine (DRUG), High-Dose trivalent inactivated influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT01525004?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.